ISLMF Stock — ISLMF

ISLMF (ISLMF)

Updated October 16, 2026.

ISLMF is a Stock. Total return is -49.0% over the past 0.5 years, 56.9 points behind SPY at 7.9%.

InSilico Medicine Cayman TopCo applies artificial intelligence to drug discovery and development through its proprietary Pharma.AI platform, which offers services including target identification, small molecule generation, and clinical outcome prediction across therapeutic areas such as fibrosis, oncology, and immunology. The company maintains strategic collaborations with partners including Takeda, Suzhou Ribo Life Science, and Human Life Foundation Models to advance drug candidates and develop foundation models for longevity science. The company does not currently distribute to shareholders.

ISLMF performance versus SPY

Price and return data through 2026-10-16.

Total return is -49.0% over the past 0.5 years, 56.9 points behind SPY at 7.9%.

ISLMF key facts

Asset type

Stock

Asset class

Equity

Inception date

04/22/2026

Distribution frequency

None

Last close

$4.97 (as of 2026-10-16)

Average volume

40315.0

Payout ratio

0.0%

EPS

$-4.39

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ISLMF risks and drawbacks

Total return has trailed SPY over the available window.

Who may consider ISLMF — and who may not

It is a weaker fit for investors who need monthly cash flow (ISLMF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on ISLMF

• All tickers starting with I

Tagged: Healthcare.

Frequently asked questions